Fundraising Fox

Kinam Hong

Investor

Partner, Sofinnova Partners - Crossover Strategy at Sofinnova Partners

Paris, Île-de-France, France

About

Partner with the Sofinnova Crossover Strategy who joined in January 2017, focused on later-stage biopharmaceutical investing. Previously co-managed the Exane Equinox healthcare fund and spent a decade as a biotech investor/analyst, including at Citigroup Investment Research, and earlier worked in product and business development at Sanofi. He is a physician and scientist with degrees from the University of Florida, plus a CFA and an INSEAD MBA.

Invests in

Biotech

Experience

  1. MedSci AdvisorsSenior Investment Advisor2014 — 2015
  2. Exane Asset ManagementCo-Fund Manager/Portfolio Manager2011 — 2013
  3. Proprietary Life SciencesSenior Investment Manager2009 — 2011New York City Metropolitan Area
  4. CitiResearch Analyst2006 — 2009New York City Metropolitan Area
  5. Sanofi PasteurSenior Manager2003 — 2006Miami, Lyon Area, France, Toronto
  6. Mount Sinai Cabrini/New York Eye & EarResident Physician1999 — 2001New York

Education

  1. INSEADMaster of Business Administration (M.B.A.), Healthcare Innovation and Finance
  2. University of Florida College of MedicineDoctor of Medicine (M.D.)1995 — 1999
  3. University of FloridaBachelor’s Degree, Biochemistry and Molecular Biology1991 — 1995

Skills & more

Start-ups1Cross-functional Team Leadership1Competitive Analysis1Product Development1Market Analysis1Marketing Strategy1Mergers & Acquisitions1Due Diligence1Strategy2Management1

Languages English · French · Korean · Spanish

  • CFACFA Institute

From Kinam's professional profile.

Same school

Shared employers

Colleagues at Sofinnova Partners